| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3048436 | Clinical Neurophysiology | 2006 | 11 Pages |
Abstract
These results suggest the importance of genetic determinants of the dopaminergic system in understanding the P300 as a risk marker for substance abuse using an integrative developmental perspective.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Steven M. Berman, Ernest P. Noble, Tim Antolin, Courtney Sheen, Bradley T. Conner, Terry Ritchie,